Show
Sort by
-
- Journal Article
- A1
- open access
Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia
-
CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment
(2022) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 197(supplement 1). p.118-119 -
- Journal Article
- A1
- open access
Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies : a EuroFlow study
-
- Journal Article
- A1
- open access
Clinical outcomes of second relapsed and refractory first relapsed paediatric AML : a retrospective study within the NOPHO‐DB SHIP consortium
-
- Journal Article
- A1
- open access
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics
-
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
-
Prospective, real-time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma in Belgium
-
GATA2 deficiency and haematopoietic stem cell transplantation : challenges for the clinical practitioner
-
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil : final analysis of the Complement 1 phase 3 trial
-
Phase III randomized AUGMENT study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with relapsed/refractory indolent non-hodgkin lymphoma